Author

Inmaculada Gilaberte

Observed names: Gilaberte Inmaculada, Gilaberte-Asín, Inmaculada, I Gilaberte, I Gilaberte Asín, I Gilaberte-Asin, I. Gilaberte, Inmaculada Gilaberte Asín, Inmaculada Gilaberte-Asín

Institution: Faes Farma (Spain)

Observed institutions: Universidad San Pablo CEU, Universitat Autònoma de Barcelona, Eli Lilly (United States), Hospital de Sant Pau, TiGenix (Spain), Centro de Investigación Biomédica en Red de Salud Mental, Hospital Universitario Miguel Servet, Eli Lilly (Spain), Hospital Universitario de La Princesa, Faes Farma (Spain), Hospital Universitari de Girona Doctor Josep Trueta, Takeda (Japan), Universidad Autónoma de Madrid

ORCID: 0000-0002-3811-9811

Observed ORCID: 0000-0002-3811-9811

OpenAlex ID: A5063639716

Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment

1997 · Victor Pérez, Inmaculada Gilaberte, et al. · The Lancet · 303

Worse Quality of Life for Children With Newly Diagnosed Attention-Deficit/Hyperactivity Disorder, Compared With Asthmatic and Healthy Children

2005 · Rodrigo Escobar, Cesar A. Soutullo, et al. · PEDIATRICS · 192

Follow-up Study to Evaluate the Long-term Safety and Efficacy of Darvadstrocel (Mesenchymal Stem Cell Treatment) in Patients With Perianal Fistulizing Crohn’s Disease: ADMIRE-CD Phase 3 Randomized Controlled Trial

2021 · Damián Garcia-Olmo, Inmaculada Gilaberte, et al. · Diseases of the Colon & Rectum · 159

Symptomatic remission and social/vocational functioning in outpatients with schizophrenia: Prevalence and associations in a cross-sectional study

2007 · Luis San, Antonio Ciudad, et al. · European Psychiatry · 129

Duloxetine in the prevention of relapse of major depressive disorder: Double-blind placebo-controlled study

2006 · David G. Perahia, Inmaculada Gilaberte, et al. · The British Journal of Psychiatry · 94

PDF

Social and occupational functioning impairment in patients in partial versus complete remission of a major depressive disorder episode. A six-month prospective epidemiological study

2009 · I. Romera, V. Perez, et al. · European Psychiatry · 91

Residual symptoms and functioning in depression, does the type of residual symptom matter? A post-hoc analysis

2013 · Irene Romera, Víctor Pérez, et al. · BMC Psychiatry · 89

PDF

Safety and Efficacy of Intracoronary Infusion of Allogeneic Human Cardiac Stem Cells in Patients With ST-Segment Elevation Myocardial Infarction and Left Ventricular Dysfunction: A Multicenter Randomized, Double-Blind, and Placebo-Controlled Clinical Trial

2018 · Francisco Fernández-Avilés, Ricardo Sanz-Ruiz, et al. · Circulation Research · 87

PDF

Recovery from schizophrenia: Results from a 1-year follow-up observational study of patients in symptomatic remission

2009 · Julio Bobes, Antonio Ciudad, et al. · Schizophrenia Research · 87

Augmentation of Fluoxetine's Antidepressant Action by Pindolol: Analysis of Clinical, Pharmacokinetic, and Methodologic Factors

2001 · Victor Pérez, Dolors Puigdemont, et al. · Journal of Clinical Psychopharmacology · 70

Olanzapine as Long-Term Adjunctive Therapy in Treatment-Resistant Bipolar Disorder

2001 · Eduard Vieta, María Reinares, et al. · Journal of Clinical Psychopharmacology · 67

Evaluation of atomoxetine for first-line treatment of newly diagnosed, treatment-naïve children and adolescents with attention deficit/hyperactivity disorder

2009 · Alonso Montoya, Amaia Hervas, et al. · Current Medical Research and Opinion · 64

Relationship of Somatic Symptoms With Depression Severity, Quality of Life, and Health Resources Utilization in Patients With Major Depressive Disorder Seeking Primary Health Care in Spain

2008 · Javier García-Campayo, José Luis Ayuso-Mateos, et al. · The Primary Care Companion to The Journal of Clinical Psychiatry · 64

Efficacy of lifestyle interventions in physical health management of patients with severe mental illness

2011 · Fernando Chacón, Fernando Mora, et al. · Annals of General Psychiatry · 61

PDF

Generalized anxiety disorder, with or without co-morbid major depressive disorder, in primary care: Prevalence of painful somatic symptoms, functioning and health status

2010 · Irene Romera, Sabela Fernández-Pérez, et al. · Journal of Affective Disorders · 61

Fluoxetine in the Prevention of Depressive Recurrences: A Double-Blind Study

2001 · Inmaculada Gilaberte, Angel Luis Montejo, et al. · Journal of Clinical Psychopharmacology · 60

Remission in schizophrenia: Results from a 1-year follow-up observational study

2009 · Antonio Ciudad, Enric Álvarez, et al. · Schizophrenia Research · 57

Optimal cutoff point of the Hamilton Rating Scale for Depression according to normal levels of social and occupational functioning

2010 · Irene Romera, Víctor Pérez, et al. · Psychiatry Research · 53

Olanzapine Orally Disintegrating Tablet: A Review of Efficacy and Compliance

2008 · Luis San, Marta Casillas, et al. · CNS Neuroscience & Therapeutics · 46

PDF

Early Response and Remission as Predictors of a Good Outcome of a Major Depressive Episode at 12-Month Follow-Up: A Prospective, Longitudinal, Observational Study

2011 · Antonio Ciudad, Enrique Álvarez, et al. · The Journal of Clinical Psychiatry · 34

Duloxetine in the treatment of major depressive disorder: an open-label study

2007 · James I Hudson, David G Perahia, et al. · BMC Psychiatry · 34

PDF

Systematic depression screening in high-risk patients attending primary care: a pragmatic cluster-randomized trial

2013 · Irene Romera, Ángel L Montejo, et al. · BMC Psychiatry · 33

PDF

Early Switch Strategy in Patients With Major Depressive Disorder: A Double-Blind, Randomized Study

2012 · Irene Romera, Victor Pérez, et al. · Journal of Clinical Psychopharmacology · 31

The Schizophrenia Outpatient Health Outcomes (SOHO) study: 3-year results of antipsychotic treatment discontinuation and related clinical factors in Spain

2007 · Antonio Ciudad, Josep María Haro, et al. · European Psychiatry · 30

Treatment benefits of duloxetine in major depressive disorder as assessed by number needed to treat

2006 · John Cookson, Inmaculada Gilaberte, et al. · International Clinical Psychopharmacology · 29

Works count: 96

Citation count: 2,517

H-index: 26

I10-index: 46